You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

SBIR: Letter from Biotech CEOs

The letter, signed by over 280 biotech executives, emphasizes support for restoring eligibility in the SBIR program to venture-backed bioscience companies.

The letter, signed by over 280 biotech executives, emphasizes support for restoring eligibility in the SBIR program to venture-backed bioscience companies.

Read the letter